Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Stokes W, Pitout J, Campbell L, Church D, Gregson D. Rapid detection of carbapenemase-producing organisms directly from blood cultures positive for Gram-negative bacilli. Eur J Clin Microbiol Infect Dis 2020;40:381-384. [PMID: 32780248 DOI: 10.1007/s10096-020-04005-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2020] [Accepted: 07/31/2020] [Indexed: 10/23/2022]

For:	Stokes W, Pitout J, Campbell L, Church D, Gregson D. Rapid detection of carbapenemase-producing organisms directly from blood cultures positive for Gram-negative bacilli. Eur J Clin Microbiol Infect Dis 2020;40:381-384. [PMID: 32780248 DOI: 10.1007/s10096-020-04005-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2020] [Accepted: 07/31/2020] [Indexed: 10/23/2022]

Number

Cited by Other Article(s)

Simner PJ, Pitout JDD, Dingle TC. Laboratory detection of carbapenemases among Gram-negative organisms. Clin Microbiol Rev 2024;37:e0005422. [PMID: 39545731 PMCID: PMC11629623 DOI: 10.1128/cmr.00054-22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2024] Open

Abstract

SUMMARYThe carbapenems remain some of the most effective options available for treating patients with serious infections due to Gram-negative bacteria. Carbapenemases are enzymes that hydrolyze carbapenems and are the primary method driving carbapenem resistance globally. Detection of carbapenemases is required for patient management, the rapid implementation of infection prevention and control (IP&C) protocols, and for epidemiologic purposes. Therefore, clinical and public health microbiology laboratories must be able to detect and report carbapenemases among predominant Gram-negative organisms from both cultured isolates and direct from clinical specimens for treatment and surveillance purposes. There is not a "one size fits all" laboratory approach for the detection of bacteria with carbapenemases, and institutions need to determine what fits best with the goals of their antimicrobial stewardship and IP&C programs. Luckily, there are several options and approaches available for clinical laboratories to choose methods that best suits their individual needs. A laboratory approach to detect carbapenemases among bacterial isolates consists of two steps, namely a screening process (e.g., not susceptible to ertapenem, meropenem, and/or imipenem), followed by a confirmation test (i.e., phenotypic, genotypic or proteomic methods) for the presence of a carbapenemase. Direct from specimen testing for the most common carbapenemases generally involves detection via rapid, molecular approaches. The aim of this article is to provide brief overviews on Gram-negative bacteria carbapenem-resistant definitions, types of carbapenemases, global epidemiology, and then describe in detail the laboratory methods for the detection of carbapenemases among Gram-negative bacteria. We will specifically focus on the Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex.

Collapse

Munguia-Ramos D, Xancal-Salvador LF, Esteban-Kenel V, Ortiz-Conchi N, Jaimes-Aquino RA, Mendoza-Rojas M, Cervantes-Sánchez A, Méndez-Ramos S, Rivera-Villegas HO, Rajme-Lopez S, Tamez-Torres KM, Roman-Montes CM, Martínez-Gamboa A, Bobadilla del-Valle M, Sifuentes-Osornio J, Ponce-de-Leon A, Gonzalez-Lara MF, Martinez-Guerra BA. Rapid Detection of Carbapenemases Using NG-Test^® CARBA 5 in Positive Blood Cultures: A Diagnostic Test Study. Antibiotics (Basel) 2024;13:1105. [PMID: 39596798 PMCID: PMC11591157 DOI: 10.3390/antibiotics13111105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2024] [Revised: 11/14/2024] [Accepted: 11/16/2024] [Indexed: 11/29/2024] Open

Affiliation(s)

Diana Munguia-Ramos Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (D.M.-R.); (H.O.R.-V.); (S.R.-L.); (K.M.T.-T.); (C.M.R.-M.); (A.P.-d.-L.); (M.F.G.-L.)
Luis Fernando Xancal-Salvador Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Verónica Esteban-Kenel Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Narciso Ortiz-Conchi Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Ricardo Antonio Jaimes-Aquino Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Miguel Mendoza-Rojas Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Axel Cervantes-Sánchez Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Steven Méndez-Ramos Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Hector Orlando Rivera-Villegas Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (D.M.-R.); (H.O.R.-V.); (S.R.-L.); (K.M.T.-T.); (C.M.R.-M.); (A.P.-d.-L.); (M.F.G.-L.)
Sandra Rajme-Lopez Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (D.M.-R.); (H.O.R.-V.); (S.R.-L.); (K.M.T.-T.); (C.M.R.-M.); (A.P.-d.-L.); (M.F.G.-L.)
Karla Maria Tamez-Torres Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (D.M.-R.); (H.O.R.-V.); (S.R.-L.); (K.M.T.-T.); (C.M.R.-M.); (A.P.-d.-L.); (M.F.G.-L.) Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Carla Marina Roman-Montes Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (D.M.-R.); (H.O.R.-V.); (S.R.-L.); (K.M.T.-T.); (C.M.R.-M.); (A.P.-d.-L.); (M.F.G.-L.) Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Areli Martínez-Gamboa Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Miriam Bobadilla del-Valle Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Jose Sifuentes-Osornio General Direction, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico;
Alfredo Ponce-de-Leon Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (D.M.-R.); (H.O.R.-V.); (S.R.-L.); (K.M.T.-T.); (C.M.R.-M.); (A.P.-d.-L.); (M.F.G.-L.)
Maria Fernanda Gonzalez-Lara Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (D.M.-R.); (H.O.R.-V.); (S.R.-L.); (K.M.T.-T.); (C.M.R.-M.); (A.P.-d.-L.); (M.F.G.-L.) Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)
Bernardo Alfonso Martinez-Guerra Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (D.M.-R.); (H.O.R.-V.); (S.R.-L.); (K.M.T.-T.); (C.M.R.-M.); (A.P.-d.-L.); (M.F.G.-L.) Clinical Microbiology Laboratory, Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, 15 Vasco de Quiroga, Belisario Domínguez Secc 16, Tlalpan, Mexico City 14080, Mexico; (L.F.X.-S.); (V.E.-K.); (N.O.-C.); (R.A.J.-A.); (M.M.-R.); (A.C.-S.); (S.M.-R.); (A.M.-G.); (M.B.d.-V.)

Collapse

Volland H, Ballesté-Delpierre C, Szabó D, Gonzalez C, Takissian J, Aszalos AZ, Ostorhazi E, Farkas S, Kamotsay K, Rosenmoller M, Stankov-Pugès M, Francius L, Boutigny L, Sivan V, Simon S, Gelhaye S, Bosch J, Vila J, Naas T. Rapid detection of CTX-M-type ESBLs and carbapenemases directly from biological samples using the BL-DetecTool. J Antimicrob Chemother 2022;77:2867-2875. [PMID: 35978470 DOI: 10.1093/jac/dkac264] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Accepted: 07/15/2022] [Indexed: 11/12/2022] Open

Affiliation(s)

Hervé Volland Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, 91191 Gif-sur-Yvette, France
Clara Ballesté-Delpierre University of Barcelona, Institute for Global Health (ISGlobal), Hospital Clínic - Barcelona, Spain
Dóra Szabó Semmelweis University, Institute of Medical Microbiology, Budapest, Hungary
Camille Gonzalez Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Bacteriology-Hygiene unit, Le Kremlin-Bicêtre, France
Julie Takissian Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Bacteriology-Hygiene unit, Le Kremlin-Bicêtre, France
Albert Zoltan Aszalos Semmelweis University, Health Services Management Training Centre, Budapest, Hungary
Eszter Ostorhazi Semmelweis University, Institute of Medical Microbiology, Budapest, Hungary
Szilvia Farkas Semmelweis University, Health Services Management Training Centre, Budapest, Hungary
Katalin Kamotsay Central Microbiology Laboratory, Central Hospital of Southern Pest National Institute of Hematology and Infectious Disease, Budapest, Hungary
Magda Rosenmoller IESE Bussiness School, Barcelona, Spain
Milovan Stankov-Pugès NG Biotech, R&D Department, Guipry, France
Laura Francius NG Biotech, R&D Department, Guipry, France
Laure Boutigny NG Biotech, R&D Department, Guipry, France
Virginie Sivan Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, 91191 Gif-sur-Yvette, France
Stéphanie Simon Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, 91191 Gif-sur-Yvette, France
Stéphanie Gelhaye Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, 91191 Gif-sur-Yvette, France
Jordi Bosch University of Barcelona, Institute for Global Health (ISGlobal), Hospital Clínic - Barcelona, Spain.,University of Barcelona, Hospital Clínic, Department of Clinical Microbiology - CDB, Barcelona, Spain
Jordi Vila University of Barcelona, Institute for Global Health (ISGlobal), Hospital Clínic - Barcelona, Spain.,University of Barcelona, Hospital Clínic, Department of Clinical Microbiology - CDB, Barcelona, Spain.,CIBER de Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain
Thierry Naas Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Bacteriology-Hygiene unit, Le Kremlin-Bicêtre, France.,Team 'Resist' UMR1184 'Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB)', INSERM, University Paris-Saclay, CEA, LabEx LERMIT, Faculty of Medicine, Le Kremlin-Bicêtre, France.,Associated French National Reference Center for Antibiotic Resistance: Carbapenemase-producing Enterobacterales, Le Kremlin-Bicêtre, France

Collapse

García-Rivera C, Parra-Grande M, Merino E, Boix V, Rodríguez JC. Concordance of the Filmarray Blood Culture Identification Panel 2 and classical microbiological methods in a bacteriemia diagnostic unit. Diagn Microbiol Infect Dis 2022;104:115787. [DOI: 10.1016/j.diagmicrobio.2022.115787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2022] [Revised: 07/20/2022] [Accepted: 08/06/2022] [Indexed: 11/24/2022]

Comini S, Bianco G, Boattini M, Banche G, Ricciardelli G, Allizond V, Cavallo R, Costa C. Evaluation of a diagnostic algorithm for rapid identification of Gram-negative species and detection of extended-spectrum β-lactamase and carbapenemase directly from blood cultures. J Antimicrob Chemother 2022;77:2632-2641. [DOI: 10.1093/jac/dkac230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Accepted: 06/09/2022] [Indexed: 11/13/2022] Open

Abstract Abstract Objectives To evaluate a rapid diagnostic algorithm based on MALDI-TOF MS, lateral flow immunoassays (LFIAs) and molecular testing performed directly from positive blood cultures (BCs) for Gram-negative species identification and detection of CTX-M extended-spectrum β-lactamases and main carbapenemases. Methods Non-duplicate BCs positive to Gram-negative bacteria at microscope examination were subjected to species identification by direct MALDI-TOF MS following recovery of bacterial pellet by Rapid MBT Sepsityper® kit. Subsequently, NG-Test® CARBA 5 and NG-Test® CTX-M MULTI LFIAs were performed according to identified microbial species. Eazyplex® SuperBug CRE molecular assay was performed in cases of NG-Test® CARBA 5 negative results in patients with documented carbapenemase-producers carriage. Results of rapid diagnostic workflow were compared with those obtained by conventional diagnostic routine. Results Overall, the direct MALDI-TOF MS protocol allowed reliable identification to the species level of 92.1% of the 2133 monomicrobial BCs. Rate of matched identification was significantly higher for Enterobacterales (97.3%) in comparison to non-fermenting Gram-negative species (80.2%), obligate anaerobic bacteria (42.1%) and fastidious Gram-negative species (41.5%). The overall sensitivity of NG-Test® CARBA 5 and NG-Test® CTX-M MULTI was 92.2% and 91.6%, respectively. Integration of Easyplex® SuperBug CRE allowed the detection of blaKPC mutants associated with ceftazidime/avibactam resistance, reaching 100% sensitivity in carbapenemase detection. Both LFIAs and molecular testing showed no false-positive results. Conclusions Algorithms based on MALDI-TOF MS, LFIAs and molecular testing may represent a cost-effective tool to timely identify Gram-negative species and detect resistance markers directly from BCs. According to local epidemiology, these results may allow antimicrobial stewardship interventions including prompt use of new approved drugs. Collapse